Calidi Biotherapeutics, Inc.
CLDWW- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001855485
No open-market purchases or sales by Calidi Biotherapeutics, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesCLDI
13F holders, Q4 2021
Institutional positions in Calidi Biotherapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- +23 vs. Q3 2021
- Shares held
- 5.80M
- +5.80M vs. Q3 2021
- Total value
- $3.01M
- +$3.01M vs. Q3 2021
- New holders
- 23
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLDWW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 1 | $1.01K |
| Q3 2024 | 16 | $99.4K |
| Q2 2024 | 17 | $281.5K |
| Q1 2024 | 17 | $385.1K |
| Q4 2023 | 18 | $384.0K |
| Q3 2023 | 22 | $1.64M |
| Q2 2023 | 22 | $866.3K |
| Q1 2023 | 24 | $366.1K |
| Q4 2022 | 25 | $350.0K |
| Q3 2022 | 27 | $479.9K |
| Q2 2022 | 28 | $767.0K |
| Q1 2022 | 29 | $2.83M |
| Q4 2021 | 23 | $3.01M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Calidi Biotherapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Apollo Management Holdings, L.P. | 989,999 | $495.0K | 0.00% | +989,999 | New |
| Woodline Partners LP | 990,000 | $495.0K | 0.01% | +990,000 | New |
| Polar Asset Management Partners Inc. | 742,563 | $371.0K | 0.00% | +742,563 | New |
| Finepoint Capital LP | 655,200 | $328.0K | 0.08% | +655,200 | New |
| Beryl Capital Management LLC | 629,999 | $315.0K | 0.02% | +629,999 | New |
| Highbridge Capital Management LLC | – | $254.0K | 0.01% | – | New |
| Governors Lane LP | 350,000 | $179.0K | 0.01% | +350,000 | New |
| Parallax Volatility Advisers, L.P. | 323,142 | $162.0K | 0.00% | +323,142 | New |
| Periscope Capital Inc. | 287,400 | $144.0K | 0.00% | +287,400 | New |
| Wolverine Asset Management LLC | 114,367 | $57.0K | 0.00% | +114,367 | New |
| 683 Capital Management, LLC | 100,000 | $51.0K | 0.00% | +100,000 | New |
| Q Global Advisors, LLC | 100,000 | $50.0K | 0.01% | +100,000 | New |
| Sona Asset Management (US) LLC | 90,898 | $45.0K | 0.02% | +90,898 | New |
| Walleye Capital LLC | 31,529 | $16.0K | 0.00% | +31,529 | New |
| Alpine Global Management, LLC | 25,200 | $13.0K | 0.00% | +25,200 | New |
| Cohen & Co Financial Management, LLC | 25,000 | $13.0K | 0.01% | +25,000 | New |
| Prelude Capital Management, LLC | 22,629 | $11.0K | 0.00% | +22,629 | New |
| Walleye Trading LLC | 20,052 | $10.0K | 0.00% | +20,052 | New |
| UBS Group AG | 1,175 | $1.00K | 0.00% | +1,175 | New |
| CNH Partners LLC | 49,998 | – | – | +49,998 | New |
| Radcliffe Capital Management, L.P. | 199,999 | – | – | +199,999 | New |
| Segantii Capital Management Ltd | 25,000 | – | – | +25,000 | New |
| Boothbay Fund Management, LLC | 22,626 | – | – | +22,626 | New |